Correlation Between Inovio Pharmaceuticals and BridgeBio Pharma
Can any of the company-specific risk be diversified away by investing in both Inovio Pharmaceuticals and BridgeBio Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inovio Pharmaceuticals and BridgeBio Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inovio Pharmaceuticals and BridgeBio Pharma, you can compare the effects of market volatilities on Inovio Pharmaceuticals and BridgeBio Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inovio Pharmaceuticals with a short position of BridgeBio Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inovio Pharmaceuticals and BridgeBio Pharma.
Diversification Opportunities for Inovio Pharmaceuticals and BridgeBio Pharma
0.49 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Inovio and BridgeBio is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Inovio Pharmaceuticals and BridgeBio Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BridgeBio Pharma and Inovio Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inovio Pharmaceuticals are associated (or correlated) with BridgeBio Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BridgeBio Pharma has no effect on the direction of Inovio Pharmaceuticals i.e., Inovio Pharmaceuticals and BridgeBio Pharma go up and down completely randomly.
Pair Corralation between Inovio Pharmaceuticals and BridgeBio Pharma
Considering the 90-day investment horizon Inovio Pharmaceuticals is expected to under-perform the BridgeBio Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Inovio Pharmaceuticals is 1.03 times less risky than BridgeBio Pharma. The stock trades about -0.03 of its potential returns per unit of risk. The BridgeBio Pharma is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 913.00 in BridgeBio Pharma on September 2, 2024 and sell it today you would earn a total of 1,796 from holding BridgeBio Pharma or generate 196.71% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inovio Pharmaceuticals vs. BridgeBio Pharma
Performance |
| Timeline |
| Inovio Pharmaceuticals |
| BridgeBio Pharma |
Inovio Pharmaceuticals and BridgeBio Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inovio Pharmaceuticals and BridgeBio Pharma
The main advantage of trading using opposite Inovio Pharmaceuticals and BridgeBio Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inovio Pharmaceuticals position performs unexpectedly, BridgeBio Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BridgeBio Pharma will offset losses from the drop in BridgeBio Pharma's long position.| Inovio Pharmaceuticals vs. Novavax | Inovio Pharmaceuticals vs. Vaxart Inc | Inovio Pharmaceuticals vs. Enveric Biosciences | Inovio Pharmaceuticals vs. Ocean Biomedical |
| BridgeBio Pharma vs. Blueprint Medicines Corp | BridgeBio Pharma vs. Amylyx Pharmaceuticals | BridgeBio Pharma vs. Day One Biopharmaceuticals | BridgeBio Pharma vs. Terns Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |